Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3034950rdf:typepubmed:Citationlld:pubmed
pubmed-article:3034950lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3034950lifeskim:mentionsumls-concept:C0020615lld:lifeskim
pubmed-article:3034950lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:3034950lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:3034950lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:3034950lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:3034950lifeskim:mentionsumls-concept:C0036085lld:lifeskim
pubmed-article:3034950pubmed:issue1lld:pubmed
pubmed-article:3034950pubmed:dateCreated1987-7-23lld:pubmed
pubmed-article:3034950pubmed:abstractTextWe studied the influence of a hypertonic saline infusion on the counterregulatory response to insulin-induced hypoglycemia in nine normal men. When given hypertonic saline, the men had less hypoglycemia in response to insulin, both acutely and in the recovery phase (P less than 0.01), and released 34% more glucagon (P less than 0.05) than when they were water loaded. The total integrated ACTH, cortisol, epinephrine, norepinephrine, and GH responses to hypoglycemia were similar after saline and water loading. After the saline load, the mean plasma vasopressin level rose from 11.0 +/- 2.2 (+/- SEM) to 20.9 +/- 2.9 pg/mL in response to insulin-induced hypoglycemia. In contrast, after the water load, vasopressin levels were undetectable (less than 2 pg/mL) and they increased only to 2.6 +/- 0.4 pg/mL with hypoglycemia. There was a significant positive correlation between basal plasma vasopressin and nadir glucose concentrations and a significant negative correlation between basal plasma vasopressin and the integrated fall in glucose after insulin administration (P less than 0.01 and P less than 0.025, respectively). The difference in the glycemic response to insulin may be related to the high vasopressin levels after saline loading, which could, either directly and/or through enhanced glucagon release, increase hepatic glucose production and thus limit the hypoglycemic response to insulin.lld:pubmed
pubmed-article:3034950pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034950pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034950pubmed:languageenglld:pubmed
pubmed-article:3034950pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034950pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3034950pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034950pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034950pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034950pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034950pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034950pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034950pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034950pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034950pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3034950pubmed:statusMEDLINElld:pubmed
pubmed-article:3034950pubmed:monthJullld:pubmed
pubmed-article:3034950pubmed:issn0021-972Xlld:pubmed
pubmed-article:3034950pubmed:authorpubmed-author:MajzoubJ AJAlld:pubmed
pubmed-article:3034950pubmed:authorpubmed-author:AdlerG KGKlld:pubmed
pubmed-article:3034950pubmed:issnTypePrintlld:pubmed
pubmed-article:3034950pubmed:volume65lld:pubmed
pubmed-article:3034950pubmed:ownerNLMlld:pubmed
pubmed-article:3034950pubmed:authorsCompleteYlld:pubmed
pubmed-article:3034950pubmed:pagination116-21lld:pubmed
pubmed-article:3034950pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:3034950pubmed:meshHeadingpubmed-meshheading:3034950-...lld:pubmed
pubmed-article:3034950pubmed:meshHeadingpubmed-meshheading:3034950-...lld:pubmed
pubmed-article:3034950pubmed:meshHeadingpubmed-meshheading:3034950-...lld:pubmed
pubmed-article:3034950pubmed:meshHeadingpubmed-meshheading:3034950-...lld:pubmed
pubmed-article:3034950pubmed:meshHeadingpubmed-meshheading:3034950-...lld:pubmed
pubmed-article:3034950pubmed:meshHeadingpubmed-meshheading:3034950-...lld:pubmed
pubmed-article:3034950pubmed:meshHeadingpubmed-meshheading:3034950-...lld:pubmed
pubmed-article:3034950pubmed:meshHeadingpubmed-meshheading:3034950-...lld:pubmed
pubmed-article:3034950pubmed:meshHeadingpubmed-meshheading:3034950-...lld:pubmed
pubmed-article:3034950pubmed:meshHeadingpubmed-meshheading:3034950-...lld:pubmed
pubmed-article:3034950pubmed:meshHeadingpubmed-meshheading:3034950-...lld:pubmed
pubmed-article:3034950pubmed:meshHeadingpubmed-meshheading:3034950-...lld:pubmed
pubmed-article:3034950pubmed:meshHeadingpubmed-meshheading:3034950-...lld:pubmed
pubmed-article:3034950pubmed:year1987lld:pubmed
pubmed-article:3034950pubmed:articleTitleInfluence of infused hypertonic saline on the response to insulin-induced hypoglycemia in man.lld:pubmed
pubmed-article:3034950pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3034950pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3034950lld:pubmed